Genetics components in patients with temporal lobe epilepsy;Factores genéticos asociados a la epilepsia del lóbulo temporal

Revista de Neurologia

Volumn 49, Issue 10, 2009, Pages 541-546

  Herrera Peco, I ^a   Fernandez Millares V ^a   Pastor, J ^a   Hernando Requejo, V ^b   Sola, R G ^a   Alonso Cerezo, C ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b Hospital de Madrid Norte Sanchinarro   (Spain)

Author keywords

Ionic channels; Molecular genetic; Mutations; Polymorphisms; Temporal lobe epilepsy

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; APOLIPOPROTEIN E; GABBR1 PROTEIN; INTERLEUKIN 1BETA; PRION PROTEIN; PRODYNORPHIN; SCN1B PROTEIN; SHAKER POTASSIUM CHANNEL; SHAL POTASSIUM CHANNEL; SODIUM CHANNEL; SODIUM CHANNEL NAV1.1; UNCLASSIFIED DRUG;

CORRELATION ANALYSIS; DNA POLYMORPHISM; EPILEPTOGENESIS; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; HEREDITY; HUMAN; MOLECULAR GENETICS; PATHOPHYSIOLOGY; REVIEW; TEMPORAL LOBE EPILEPSY;

EID: 73949098613     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4910.2009165     Document Type: Review

References (64)

1. Hauser WA. Incidence and prevalence. In Engel J Jr, Pedley T, eds. Epilepsy. a comprehensive textbook. Vol. 1. Philadelphia: Lippincott-Raven; 1998. p. 47-57.
2. Serrano-Castro PJ, Sánchez-Álvarez JC, Cañadillas- Hidalgo FM, Galán-Barranco JM, Moreno-Alegre V, Mercadé- Cerdá JM. Guía de práctica clínica de consenso de la Sociedad Andaluza de Epilepsia para el diagnóstico y tratamiento del paciente con una primera crisis epiléptica en situaciones de urgencia. Rev Neurol 2009; 48: 39-50.
3. Herrera-Peco I, Sola RG, Osejo V, Wix-Ramos R, Pastor J. Participación de los astrocitos activados mediante albúmina en la epileptogénesis. Rev Neurol 2008; 47: 582-7.
4. Turnbull J, Lohi H, Kearney JA, Rouleau GA, Delgado-Escueta AV, Meisler MH, et al. Sacred disease secrets revealed: the genetics of human epilepsy. Human Mol Gen 2005; 14: 2491-500.
5. Alving J. What is intractable epilepsy? In Johannessen G, Sillanpä T, eds. Intractable epilepsy. Petersfield: Wrightson Biomedical Publishing; 1991. p. 1-12.
6. Sola RG, Hernando V, Pastor J, Navarrete EG, De Felipe J, Alijarde MT, et al. Epilepsia farmacorresistente del lóbulo temporal. Exploración con electrodos del foramen oval y resultados quirúrgicos. Rev Neurol 2005; 41: 4-16.
7. Pastor J, Hernando-Requejo V, Domínguez-Gadea L, De Llano I, Meilán-Paz ML, Martínez-Chacón JL, et al. Impacto de la experiencia sobre los resultados quirúrgicos en la epilepsia del lóbulo temporal. Rev Neurol 2005; 41: 709-16.
8. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for a revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981; 22: 489-501.
9. Fernández-Millares V, Alonso-Cerezo C, Pastor-Gómez J, Herrera-Peco I, Hernando-Requejo V, Sola RG. Actualización sobre las bases genéticas de la epilepsia y consejo genético. In AEBM, ed. Taller del Laboratorio Clínico. Madrid: AEBM; 2009. p. 200-19.
10. Vadlamudi L, Scheffer IE, Berkovic SF. Genetic of temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 2003; 74: 1359-61.
11. Pastor J, Sola RG. Utility of foramen ovale electrodes in temporal lobe epilepsy surgery. Res Adv Epilepsy 2008; 1: 1-9.
12. Cavalleri GL, Lynch JM, Depondt C, Burley MW, Wood NW, Sisodiya SM, et al. Failure to replicate previously reported genetic associations with sporadic temporal lobe epilepsy: where to from here? Brain 2005; 128: 1832-40.
13. Engel Jr J. Mesial temporal lobe epilepsy: what have we learned? Neuroscientist 2001; 7: 340-52.
14. Lee TS, Mane S, Eid T, Zhao H, Lin A, Guan Z, et al. Gene expression in temporal lobe epilepsy is consistent with increased release of glutamate by astrocytes. Mol Med 2007; 13: 1-13.
15. Chabrol E, Gourfinkel-An I, Scheffer IE, Picard F, Couarch P, Berkovic SF, et al. Absence of mutations in the LGI1 receptor ADAM22 gene in autosomal dominant lateral temporal epilepsy. Epilepsy Res 2007; 76: 41-8.
16. Löscher W, Schmidt D. New horizons in the development of antiepileptic drugs: the search for new targets. Epilepsy Res 2004; 60: 77-159.
17. Hernando-Requejo V. Tratamiento quirúrgico de la epilepsia del lóbulo temporal: resultados clínicos y capacidad lateralizadora y localizadora de las pruebas complementarias del estudio prequirúrgico [tesis doctoral]. URL: http://www.neurorgs.com/inv/pdf/tesisVHR.pdf. [10.02.2009].
18. Mosyagin I, Runge U, Schroeder HW, Dazert E, Vogelgesang S, Siegmund W, et al. Association of ABCB1 genetic variants 3435C>T and 2677G>T to ABCB1 mRNA and protein expression in brain tissue from refractory epilepsy patients. Epilepsia 2008; 49: 1555-61.
19. Avoli M, Louvel J, Pumain R, Köhling R. Cellular and molecular mechanisms of epilepsy in the human brain. Prog Neurobiol 2005; 77: 166-200.
20. Gu W, Brodtkorb E, Steinlein OK. LGI1 is mutated in familial temporal lobe epilepsy characterized by aphasic seizures. Ann Neurol 2002; 52: 364-7.
21. Baulac S, Gourfinkel-An I, Nabbout R, Huberfeld G, Serratosa J, Leguern E, et al. Fever, genes, and epilepsy. Lancet Neurol 2004; 3: 421-30.
22. Bovo G, Diani E, Bisulli F, Di Bonaventura C, Striano P, Gambardella A, et al. Analysis of LGI1 promoter sequence, PDYN and GABBR1 polymorphisms in sporadic and familial lateral temporal lobe epilepsy. Neurosci Lett 2008; 436: 23-6.
23. Walz R, Castro RM, Velasco TR. Surgical outcome in mesial temporal sclerosis correlates with prion protein gene variant. Neurology 2003; 61: 1204-10.
24. Salzmann A, Moulard B, Crespel A, Baldy-Moulinier M, Buresi C, Malafosse A. GABAB receptor 1 polymorphism (G1465A) and temporal lobe epilepsy. Epilepsia 2005; 46: 931-3.
25. Scheffer IE, Harkin LA, Grinton BE, Dibbens LM, Turner SJ, Zielinski MA, et al. Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B mutations. Brain 2007; 130: 100-9.
26. Colosimo E, Gambardella A, Mantegazza M, Labate A, Rusconi R, Schiavon E, et al. Electroclinical features of a family with simple febrile seizures and temporal lobe epilepsy associated with SCN1A lossof-function mutation. Epilepsia 2007; 48: 1691-6.
27. Diani E, Di Bonaventura C, Mecarelli O, Gambardella A, Elia M, Bovo G, et al. Autosomal dominant lateral temporal epilepsy: absence of mutations in ADAM22 and Kv1 channel genes encoding LGI1-associated proteins. Epilepsy Res 2008; 80: 1-8.
28. Singh B, Ogiwara I, Kaneda M, Tokonami N, Mazaki E, Baba K, et al. A Kv4.2 truncation mutation in a patient with temporal lobe epilepsy. Neurobiol Dis 2006; 24: 245-53.
29. Pastor J. Fundamentos biofísicos de la actividad neuronal. Rev Neurol 2000; 30: 741-55.
30. Isom LL. The role of sodium channels in cell adhesion. Front Biosci 2002; 7: 12-23.
31. Yu FH, Westenbroek RE, Silos-Santiago I, McCormick KA, Lawson D, Ge P, et al. Sodium channel beta4, a new disulfide-linked auxiliary subunit with similarity to beta2. J Neurosci 2003; 23: 7577-85.
32. Meadows LS, Malhotra J, Loukas A, Thyagarajan V, Kazen-Gillespie KA, Koopman MC, et al. Functional and biochemical analysis of a sodium channel beta1 subunit mutation responsible for generalized epilepsy with febrile seizures plus type 1. J Neurosci 2002; 22: 10699-709.
33. Yuan LL, Chen X. Diversity of potassium channels in neuronal dendrites. Prog Neurobiol 2006; 78: 374-89.
34. Chen H, Von Hehn C, Kaczmarek LK, Ment LR, Pober BR, Hisama FM. Functional analysis of a novel potassium channel (KCNA1) mutation in hereditary myokymia. Neurogenetics. 2007; 8: 131-5.
35. Zuberi SM, Eunson LH, Spauschus A, De Silva R, Tolmie J, Wood NW, et al. A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain 1999; 122: 817-25.
36. Eunson LH, Rea R, Zuberi SM, Youroukos S, Panayiotopoulos CP, Liguori R, et al. Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Ann Neurol 2000; 48: 647-56.
37. Rho JM, Szot P, Tempel BL, Schwartzkroin PA. Developmental seizure susceptibility of kv1.1 potassium channel knockout mice. Dev Neurosci 1999; 21: 320-7.
38. Schulte U, Thumfart JO, Klocker N, Sailer CA, Bidl W, Biniossek M, et al. The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kvbeta1. Neuron 2006; 49: 697-706.
39. Gutman GA, Chandy KG, Grissmer S, Lazdunski M, McKinnon D, Pardo LA, et al. International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol Rev 2005; 57: 473-508.
40. Ma S, Abou-Khalil B, Sutcliffe JS, Haines JL, Hedera P. The GABBR1 locus and the G1465A variant is not associated with temporal lobe epilepsy preceded by febrile seizures. BMC Med Genet 2005; 6: 13.
41. Gambardella A, Manna I, Labate A, Chifari R, La Russa A, Serra P, et al. GABAB receptor I polymorphism (G1465A) is associated with temporal lobe epilepsy. Neurology 2003; 60: 560-3.
42. Stogmann E, Zimprich A, Baumgartner C, Aull-Watschinger S, Hollt V, Zimprich F. A functional polymorphism in the prodynorphin gene promotor is associated with temporal lobe epilepsy. Ann Neurol 2002; 51: 260-3.
43. Chernova OB, Somerville RP, Cowell JK. A novel gene LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors. Oncogene 1998; 17: 2873-81.
44. Kauffman MA, Consalvo D, González-Morón D, Kochen S. Asociación entre alelos transcripcionalmente deficientes del gen de la prodinorfina y el desarrollo de epilepsia del lóbulo temporal. Revista Neurológica Argentina 2007; 32: 40-6.
45. Litt M, Buroker NE, Kondoleon S, Douglass J, Liston D, Sheehy R, et al. Chromosomal localization of the human proenkephalin and prodynorphin genes. Am J Hum Genet 1988; 42: 327-34.
46. Ottman R, Winawer, MR, Kalachikov S, Barker-Cummings C, Gilliam TC, Pedley TA, et al. LGI1 mutations in autosomal dominant partial epilepsy with auditory features. Neurology 2004; 62: 1120-6.
47. Tilgen N, Rebstock J, Horvath S, Propping P, Elger CE, Heils A. Prodynorphin gene promoter polymorphism and temporal lobe epilepsy. Ann Neurol 2003; 53: 280-2.
48. Salzmann A, Perroud N, Crespel A, Lambercy C, Malafosse A. Candidate genes for temporal lobe epilepsy: a replication study. Neurol Sci 2008; 29: 397-403.
49. Wohlin M, Sundström J, Lannfelt L, Axelsson T, Syvänen AC, Andrén B, et al. Apolipoprotein E epsilon4 genotype is independently associated with increased intima-media thickness in a recessive pattern. Lipids 2007; 42: 451-6.
50. Sporis D, Sertic J, Henigsberg N, Mahovic D, Bogdanovic N, Babic T. Association of refractory complex partial seizures with a polymorphism of ApoE genotype. J Cell Mol Med 2005; 9: 698-703.
51. De Blasi S, Montesanto A, Martino C, Dato S, De Rango F, Bruni AC, et al. APOE polymorphism affects episodic memory among non demented elderly subjects.Exp Gerontol 2009; 44: 224-7.
52. Li YJ, Hauser MA, Scott WK, Martin ER, Booze MW, Qin XJ, et al. Apolipoprotein E controls the risk and age at onset of Parkinson disease. Neurology 2004; 62: 2005-9.
53. Briellmann RJ, Torn-Broers Y, Busuttil BE, Major BJ, Kalnins RM, Olsen M, et al. APOE epsilon4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy. Neurology 2000; 55: 435-7.
54. Kumar A, Tripathi M, Pandey RM, Ramakrishnan L, Srinivas M, Luthra K. Apolipoprotein E in temporal lobe epilepsy: a case-control study. Dis Markers 2006; 22: 335-42.
55. Gambardella A, Aguglia U, Chifari R, Labate A, Manna I, Serra P, et al. ApoE epsilon4 allele and disease duration affect verbal learning in mild temporal lobe epilepsy. Epilepsia 2005; 46: 110-7.
56. Kanemoto K, Kawasaki J, Yuasa S, Kumaki T, Tomohiro O, Kaji R, et al. Increased frequency of interleukin-1beta-511T allele in patients with temporal lobe epilepsy, hippocampal sclerosis, and prolonged febrile convulsion. Epilepsia 2003; 44: 796-9.
57. Jin L, Jia Y, Zhang B, Xu Q, Fan Y, Wu L, et al. Association analysis of a polymorphism of interleukin 1β (IL-1β) gene with temporal lobe epilepsy in a Chinese population. Epilepsia 2003; 44: 1306-9.
58. Buono RJ, Ferraro TN, O'Connor MJ, Sperling MR, Ryan SG, Scattergood T, et al. Lack of association between an interleukin 1 beta (IL-1β) gene variation and refractory temporal lobe epilepsy. Epilepsia 2001; 42: 782-4.
59. Walz R, Amaral OB, Rockenbach IC, Roesler R, Izquierdo I, Cavalheiro EA, et al. Increased sensitivity to seizures I mice lacking cellular prion protein. Epilepsia 1999; 40: 1679-82.
60. Labate A, Manna I, Gambardella A, Le Piane E, La Russa A, Condino F, et al. Association between the M129V variant allele of PRNP gene and mild temporal lobe epilepsy in women. Neurosci Lett 2007; 421: 1-4.
61. Herms J, Tings T, Gall S, Madlung A, Giese A, Siebert H, et al. Evidence of presynaptic location and function of the prion protein. J Neurosci 1999; 19: 8866-75.
62. Aguzzi A, Weissmann C. Prion research: the next frontiers. Nature 1997; 389: 795-8.
63. Walz R, Castro RM, Velasco TR, Carlotti CR Jr, Sakamoto AC, Brentani RR, et al. Cellular prion protein: implications in seizures and epilepsy. Cell Mol Neurobiol 2002; 22: 249-57.
64. Pastor J, Uzcátegui YG, Gal-Iglesias B, Ortega GJ, Sola RG, Menéndez de la Prida L. Bases fisiopatológicas de la epilepsia del lóbulo temporal: estudios en humanos y animales. Rev Neurol 2006; 42: 663-73.